Novo Nordisk Aktie
63,78
EUR
-1,26
EUR
-1,94
%
60,48
CHF
-1,15
CHF
-1,86
%
Werbung
Novo Nordisk Aktie Analyse
20.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
14.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
24.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
15.05.24 | Novo Nordisk Neutral | UBS AG | |
14.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
14.05.24 | Novo Nordisk Neutral | UBS AG | |
Werbung
|
|||
08.05.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.05.24 | Novo Nordisk Overweight | Barclays Capital | |
06.05.24 | Novo Nordisk Neutral | UBS AG | |
03.05.24 | Novo Nordisk Halten | DZ BANK | |
03.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
03.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
02.05.24 | Novo Nordisk Overweight | Barclays Capital | |
02.05.24 | Novo Nordisk Neutral | UBS AG | |
02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.09.23 | Novo Nordisk Sell | UBS AG | |
05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
11.08.23 | Novo Nordisk Sell | UBS AG | |
11.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
09.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.08.23 | Novo Nordisk Sell | UBS AG | |
08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.07.23 | Novo Nordisk Sell | UBS AG | |
12.07.23 | Novo Nordisk Buy | Deutsche Bank AG | |
11.07.23 | Novo Nordisk Outperform | Credit Suisse Group | |
05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
28.06.23 | Novo Nordisk Buy | Deutsche Bank AG |
Werbung
Werbung